Q1 2026 Holdings
Filed 2026-04-17 | 79 holdings | $141.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(SGOV) | 0-3 MNTH TREASRY | 46436E718 | $70.5M | 700,000 | 49.9% |
| Spdr Series Trust(XBI) | STATE STREET SPD | 78464A870 | $36.4M | 284,900 | 25.7% |
| Sera Prognostics Inc(SERA) | CLASS A COM | 81749D107 | $4.9M | 2,396,685 | 3.4% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $657.7K | 34,800 | 0.5% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $612.8K | 16,000 | 0.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $571.8K | 2,500 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $565.0K | 20,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $547.1K | 8,300 | 0.4% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $527.7K | 11,000 | 0.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $524.7K | 6,300 | 0.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $518.7K | 8,026 | 0.4% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $512.5K | 11,948 | 0.4% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $511.5K | 8,000 | 0.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $510.6K | 6,800 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $507.5K | 15,000 | 0.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $506.9K | 3,848 | 0.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $498.8K | 5,300 | 0.4% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $491.1K | 7,000 | 0.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $488.1K | 15,000 | 0.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $484.7K | 1,465 | 0.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $483.3K | 1,500 | 0.3% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $480.9K | 2,845 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $480.2K | 15,000 | 0.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $479.2K | 80,000 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $476.9K | 19,200 | 0.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $468.1K | 641 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $467.2K | 20,000 | 0.3% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $465.7K | 6,927 | 0.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $464.1K | 19,700 | 0.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $463.0K | 22,100 | 0.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $461.9K | 5,000 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $461.9K | 12,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $460.6K | 28,000 | 0.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $456.5K | 15,141 | 0.3% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $451.9K | 9,500 | 0.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $445.6K | 6,000 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $444.9K | 28,700 | 0.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $444.6K | 30,000 | 0.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $440.0K | 19,766 | 0.3% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $438.1K | 14,000 | 0.3% |
| Immunome Inc(IMNM) | COM | 45257U108 | $437.4K | 20,000 | 0.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $433.4K | 9,000 | 0.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $431.9K | 13,000 | 0.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $419.6K | 5,000 | 0.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $412.4K | 13,000 | 0.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $408.8K | 6,000 | 0.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $402.3K | 10,000 | 0.3% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $400.1K | 14,283 | 0.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $399.5K | 11,000 | 0.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $392.6K | 71,000 | 0.3% |